BSEM Exercise Disclosure
Smith-van Vurst Andrew · SEC Form 4 · Filed Sep 17, 2026
Exercise
Calculated transaction value
$0
Smith-van Vurst Andrew Chief Operating Officer
BSEM
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
BSEM daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 7,622 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-394391
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Biostem Technologies, Inc. BSEM | Exercise | Sep 17, 2026 | $0 |
| Biostem Technologies, Inc. BSEM | Exercise | Sep 17, 2026 | $0 |
| Biostem Technologies, Inc. BSEM | Exercise | Sep 15, 2026 | $0 |
| Biostem Technologies, Inc. BSEM Current | Exercise | Sep 15, 2026 | $0 |